Genomic instability: The driving force behind refractory/relapsing Hodgkin's lymphoma

Cancers

Volumn 5, Issue 2, 2013, Pages 714-725

  Knecht, Hans ^a,b   Righolt, Christiaan ^b,c   Mai, Sabine ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

3D FISH; Genomic instability; Hodgkin's lymphoma; Nano morphology; Nuclear architecture; Reed Sternberg cell; Shelterin; Telomere

Indexed keywords

LATENT MEMBRANE PROTEIN 1; PROTEIN POT1; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER REGRESSION; CANCER STAGING; CHROMOSOME MARKER; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; FEMALE; GENE TARGETING; GENETIC ASSOCIATION; GENOMIC INSTABILITY; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LATENT MEMBRANE PROTEIN 1 GENE; LYMPHOMA CELL LINE; MALE; MOLECULAR PATHOLOGY; RECURRENT CANCER; REED STERNBERG CELL; TELOMERE; TUMOR GENE;

EID: 84878828953     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers5020714     Document Type: Article

References (32)

1. Küppers, R.; Engert, A.; Hansmann, M.L. Hodgkin lymphoma. J. Clin. Invest. 2012, 122, 3439-3447.
2. Küppers, R. New insights in the biology of Hodgkin lymphoma. Hematology Am. Soc. Hematol. Educ. Program 2012, 2012, 328-334.
3. Steidl, C.; Connors, J.M.; Gascoyne, R.D. Molecular pathogenesis of Hodgkin. s lymphoma: Increasing evidence of the importance of the microenvironment. J. Clin. Oncol. 2011, 29, 1812-1826.
4. Farrell, K.; Jarrett, R.F. The molecular pathogenesis of Hodgkin lymphoma. Histopathology 2011, 58, 15-25.
5. Schwarzer, R.; Jundt, F. Notch and NF-κB signaling pathways in the biology of classical Hodgkin lymphoma. Curr. Mol. Med. 2011, 11, 236-245.
6. Knecht, H.; Brüderlein, S.; Mai, S.; Möller, P.; Sawan, B. 3D structural and functional characterization of the transition from Hodgkin to Reed-Sternberg cells. Ann. Anat. 2010, 192, 302-308.
7. Gadji, M.; Vallente, R.; Klewes, L.; Righolt, C.; Wark L.; Kongruttanachok, N.; Knecht, H.; Mai, S. Nuclear remodeling as a mechanism for genomic instability in cancer. Adv. Cancer Res. 2011, 112, 77-126.
8. Cremer, T.; Cremer, M.; Dietzel, S.; Müller, S.; Solovei, I.; Fakan, S. Chromosome territories-a functional nuclear landscape. Curr. Opin. Cell Biol. 2006, 18, 307-316.
9. Lanctôt, C.; Cheutin, T.; Cremer, M.; Cavalli, G.; Cremer, T. Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat. Rev. Genet. 2007, 8, 104-115.
10. Solovei, I.; Kreysing, M.; Lanctôt, C.; Kösem, S.; Peichl, L.; Cremer, T.; Guck, J.; Joffe, B. Nuclear architecture of rod photoreceptor cells adapts to vision in mammalian evolution. Cell 2009, 137, 356-368.
11. Londoño-Vallejo, J.A.; Wellinger, R.J. Telomeres and telomerase dance to the rhythm of the cell cycle. Trends Biochem. Sci. 2012, 37, 391-399.
12. Chuang, T.C.; Moshir, S.; Garini, Y.; Chuang, A.Y.; Young, I.T.; Vermolen, B.; van den Doel, R.; Mougey, V.; Perrin, M.; Braun, M.; et al. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol. 2004, 2, 12.
13. Vermolen, B.J.; Garini, Y.; Mai, S.; Mougey, V.; Fest, T.; Chuang, T.C.; Chuang, A.Y.; Wark, L.; Young, I.T. Characterizing the three-dimensional organization of telomeres. Cytometry A 2005, 67, 144-150.
14. Mai, S.; Garini, Y. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J. Cell. Biochem. 2006, 97, 904-915.
15. Louis, S.F.; Vermolen, B.J.; Garini, Y.; Young, I.T.; Guffei, A.; Lichtensztejn, Z.; Kuttler, F.; Chuang, T.C.; Moshir, S.; Mougey, V.; et al. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc. Natl. Acad. Sci. USA 2005, 102, 9613-9618.
16. Lacoste, S.; Wiechec, E.; dos Santos Silva, A.G.; Guffei, A.; Williams, G.; Lowbeer, M.; Benedek, K.; Henriksson, M.; Klein, G.; Mai, S. Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells. Oncogene 2010, 29, 503-515.
17. Schermelleh, L.; Carlton, P.M.; Haase, S.; Shao, L.; Winoto, L.; Kner, P.; Burke, B.; Cardoso, M.C.; Agard, D.A.; Gustafsson, M.G.; et al. Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy. Science 2008, 320, 1332-1336.
18. Xu, L.; Blackburn, E.H. Human cancer cells harbour T-stumps, a distinct class of extremely short telomeres. Mol. Cell 2007, 28, 315-327.
19. Knecht, H.; Sawan, B.; Lichtensztejn, D.; Lemieux, B.; Wellinger, R.; Mai, S. The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells. Leukemia 2009, 23, 565-573.
20. Knecht, H.; Brüderlein, S.; Wegener, S.; Lichtensztejn, D.; Lichtensztejn, Z.; Möller P.; Mai, S. 3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps". BMC Cell Biol. 2010, 11, 99.
21. Guffei, A.; Sarkar, R.; Klewes, L.; Righolt, C.; Knecht, H.; Mai, S. Dynamic chromosomal rearrangements in Hodgkin. s lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles. Haematologica 2010, 95, 2038-2046.
22. Knecht, H.; Sawan, B.; Lichtensztejn, Z.; Lichtensztejn, D.; Mai, S. 3D Telomere FISH defines LMP1 expressing Reed-Sternberg Cells as End-Stage Cells with Telomere-poor "Ghost" Nuclei and very short Telomeres. Lab. Invest. 2010, 90, 611-619.
23. Knecht, H.; Kongruttanachok, N.; Sawan, B.; Brossard, J.; Prévost, P.; Turcotte, E.; Lichtensztejn, Z.; Lichtensztejn, D.; Mai, S. 3D telomere signatures of Hodgkin-and Reed-Sternberg cells at diagnosis identify patients with poor response to conventional chemotherapy. Transl. Oncol. 2012, 5, 269-277.
24. Lajoie, V.; Lemieux, B.; Sawan, B.; Lichtensztejn, D.; Lichtensztejn, Z.; Rowe, M.; Wellinger, R.; Mai, S.; Knecht, H. The Epstein-Barr virus (EBV) encoded oncoprotein LMP1 mediates down regulation of shelterin proteins, formation of telomere aggregates and multi-nuclearity. ASH Annual Meeting Abstracts 2010, 116, 3625.
25. Kamranvar, S.A.; Masucci, M.G. The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia 2011, 25, 1017-1025.
26. Deng, Z.; Wang, Z.; Lieberman, P.M. Telomeres and viruses: Common themes of genome maintenance. Front. Oncol. 2012, 2, 201.
27. Faumont, N.; Chanut, A.; Benard, A.; Cogne, N.; Delsol, G.; Feuillard, J.; Meggetto, F. Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin. s lymphoma. s Reed-Sternberg cells and normal B-lymphocytes. Haematologica 2009, 94, 355-363.
28. Zuercher, E.; Butticaz, C.; Wyniger, J.; Martinez, R.; Battegay, M.; Boffi El Amari, E.; Dang, T.; Egger, J.F.; Fehr, J.; Mueller-Garamvögyi, E.; et al. Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-κB activation. PLoS One 2012, 7, e32168.
29. Tiacci, E.; Döring, C.; Brune V.; van Noesel, C.J.; Klapper W.; Mechtersheimer, G.; Falini, B.; Küppers, R.; Hansmann, M.L. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. Blood 2012, 120, 4609-4620.
30. Krem, M.M.; Luo, P.; Ing, B.I.; Horwitz, M.S. The kelch protein KLHDC8B guards against mitotic errors, centrosomal amplification, and chromosomal instability. J. Biol. Chem. 2012, 287, 39083-39093.
31. Szczepanowski, M.; Masqué-Soler, N.; Oschlies, I.; Schmidt, W.; Lück, A.; Klapper, W. Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness. Hum. Pathol. 2013, in press.
32. Younes, A.; Bartlett, N.L.; Leonard, J.P.; Kennedy, D.A.; Lynch, C.M.; Sievers, E.L.; Forero-Torres, A. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N. Engl. J. Med. 2010, 363, 1812-1821.